Look out Treasury Wine (ASX:TWE), there's a new shiraz on the block

Competition in Australia's luxury wine market is heating up…

| More on:
A wine technician in overalls holds a glass of red wine up to the light and studies is closely with large wine barrels in the background, stored in a brick walled wine cellar.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Treasury Wine share price dipped 1% on Thursday despite no news having been released by the company
  • However, its iconic brand, Penfolds, featured in reports of increasing competition in the luxury wine market
  • Victorian wine maker Levantine Hill Estate has crafted a premium wine reportedly designed to compete with Penfolds' iconic Grange collection on price point

The Treasury Wine Estates Ltd (ASX: TWE) share price finished in the red today amid news a rival could be coming for a Penfolds icon.

A Victorian winery has launched its own luxury shiraz and media are reporting it could compete with Penfolds Grange.

As of Thursday's close, the Treasury Wine share price is $11.66, down 1.02% on the day.

For context, the S&P/ASX 200 Index (ASX: XJO) gained 0.12% today.

Let's take a closer look at the newest entrant in Australia's premium wine market.

Is Penfolds Grange facing new competition?

Move over Penfolds, another luxury shiraz is hitting the market. This time, it's from Victoria.

Yarra Valley winery Levantine Hill Estate has launched what is expected to be Victoria's most expensive new release wine – with an $800 per bottle price tag.  

It's released the 2017 Levantine Hill Optume Shiraz and the 2017 Levantine Hill Optume Cabernet Sauvignon.

The wines are extremely limited. Only 65 dozen of the shiraz and 58 dozen of the cabernet sauvignon will be available to purchase.

And while Levantine Hill owner and founder Elias Jreissati describes the wine as the "polar opposite" of Penfolds Grange, he told The Australian it will compete with the South Australian icon on price point.

Optume is entirely created in the Yarra Valley. Though, the bottles it's sold in are imported from France.

It's made using the region's best cabernet sauvignon and shiraz, creating what Levantine Hill managing director Samantha Jreissati describes as "the optimum expression of a GI-specific, cool climate wine".

Though, Optume is still slightly cheaper than Grange. The most affordable bottle of Grange is priced at $950 while the most expensive retails at $2,500.

Not to mention, a bottle of Penfolds Grange Hermitage Bin 1 Shiraz 1951 was sold at auction for $157,624 in December 2021, making it the most expensive bottle of Australian wine ever sold.

Treasury Wine share price snapshot

It's unlikely today's comparisons between Penfolds Grange and Levantine Hill Optume have dampened the Treasury Wine share price but the company's stock has been struggling on its own lately. It has fallen 6.3% since the start of 2022. For comparison, the ASX 200 has fallen 2.7% over the same time frame.

However, the Treasury Wine share price is still 7.4% higher than it was this time last year. That's not far off the benchmark index's 8.8% gain.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Treasury Wine Estates Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Consumer Staples & Discretionary Shares

businessman handing $100 note to another in supermarket aisle representing woolworths share price
Consumer Staples & Discretionary Shares

How much could $5,000 invested in Coles shares be worth in a year?

Bell Potter sees big returns on the cards for owners of this stock.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Consumer Staples & Discretionary Shares

What are brokers saying about A2 Milk shares?

Is it time to snap up this stock or should you keep your infant formula powder dry?

Read more »

A female Woolworths customer leans on her shopping trolley as she rests her chin in her hand thinking about what to buy for dinner while also wondering why the Woolworths share price isn't doing as well as Coles recently
Consumer Staples & Discretionary Shares

Should you buy the dip on Woolworths shares?

Is this a good time to look at the supermarket business?

Read more »

Woman in dress sitting in chair looking depressed
Consumer Staples & Discretionary Shares

Cettire share price plunges 6% after major investor pulls the plug

A 'red flag' triggered this investment company to sell out completely.

Read more »

A young woman's hands are shown close up with many blingy gold rings on her fingers and two large gold chains around her neck with dollar signs on them.
Consumer Staples & Discretionary Shares

ASX experts: Lovisa share price has 28% upside

ASX brokers are still rating Lovisa as a compelling buy today.

Read more »

Two colleagues at work looking at a tablet and smiling at a rising share price.
Consumer Staples & Discretionary Shares

Buy this top ASX 200 stock for an 18% gain and 4% dividend yield

Bell Potter has resumed coverage on this stock and is feeling very positive.

Read more »

footwear asx share price on watch represented by look holding shoe and looking intently
Consumer Staples & Discretionary Shares

Does this ASX 300 retail stock really have a 7.6% dividend yield right now?

Is a 7.67% dividend yield too good to be true?

Read more »

A person eats a meat pie on the beach... what's more Australian than that?
Consumer Staples & Discretionary Shares

Which ASX shares could be next on the menu for Ozempic?

This broker believes the market for weight-loss drugs could grow tenfold. What could it consume on its way up?

Read more »